NGS (次世代シーケンシング) サンプル調製市場：現状分析・予測（2021年～2027年）

世界のNGS (次世代シーケンシング) サンプル調製の市場規模は、予測期間中約15％のCAGRで成長すると予測されています。

NGSベースの診断への注目の高まりや、世界の癌の発生率の急増など、さまざまな要因が同市場の成長を推進しています。例えば、CDCの予測によると、米国における癌患者数は、2015年の153万4,500人から、2050年には228万6,300人へと増加し、75歳以上の成人における増加率が最も高くなると言われています。このような癌の急激な増加により、バイオテクノロジー企業や製薬企業は、NGSベースの効果的で信頼性の高い診断ツールの開発への投資を活発化させています。

当レポートでは、世界のNGS (次世代シーケンシング) サンプル調製の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法・前提因子

第3章 市場概要

第4章 エグゼクティブサマリー

第5章 世界のNGSサンプル調製市場：COVID-19の影響

第6章 世界のNGSサンプル調製市場の収益

第7章 市場分析：製品別

• ワークステーション
• 試薬・消耗品

第8章 市場分析：ライブラリー調製別

• DNA
• RNA
• ターゲットエンリッチメント
• 品質管理

第9章 市場分析：技術別

• SBS (合成シーケンシング）
• イオン半導体シーケンシング
• ナノポアシーケンシング
• その他

第10章 市場分析：用途別

• 疾病診断
• 創薬
• 農業・動物研究

第11章 市場分析：エンドユーザー別

• 学術機関・研究センター
• 病院・クリニック
• 製薬・バイオテクノロジー企業
• その他

第12章 市場分析：地域別

• 北米
• 欧州
• アジア太平洋
• その他

第13章 NGSサンプル調製：市場力学

• 市場促進要因
• 市場課題
• 影響分析

第14章 NGSサンプル調製市場の機会

第15章 NGSサンプル調製市場の動向

第16章 法規制の枠組み

第17章 需要サイド・供給サイドの分析

第18章 バリューチェーン分析

第19章 競合シナリオ

• ポーターのファイブフォース分析
• 競合情勢

第20章 企業概要

• Thermo Fisher Scientific
• Illumina Inc.
• QIAGEN N.V.
• Agilent Technologies, Inc.
• F. Hoffmann-La Roche Ltd.
• Integrated DNA Technologies, Inc.
• Beckman Coulter
• Pacific Biosciences of California
• Becton, Dickinson and Company
• Promega Corporation

第21章 免責事項

The global NGS Sample Preparation Market is anticipated to grow with an elevated CAGR of around 15% over the forecast period (2021-2027). Next-generation sequencing (NGS) is a technology used to determine the RNA or DNA sequence to study genetic variation associated with various types of diseases or other biological phenomena. With advancements in sequencing technologies and constant innovations, the protocols for sample preparation have been standardized.

The NGS sample preparation market has been growing on account of various factors including the growing emphasis on NGS-based diagnostics and surging incidences of cancer across the globe. For instance, the number of cancer cases in the US will increase 49% each year, from 1,534,500 in 2015 to 2,286,300 in 2050, with the largest percentage increase among adults aged ≥75 years, as per the predictions by CDC. This exponential increase in cancer prevalence has created a buzz among biotechnology and pharmaceutical companies for investing in the development of effective and reliable diagnostic tools based on the NGS.

Furthermore, promulgating strategic alliances among industry players and growing advancement in NGS technologies which can be used in different areas of biomedical, basic research and agriculture are other factors that are significantly driving the NGS sample preparation market globally. For example, in June 2020, 10x Genomics, Inc. and Merck collaborated for providing impactful linking of two innovative technologies: single-cell transcriptomics and pooled CRISPR screening to the researchers which will provide more detailed information to them for understanding the relationship between specific genes and disease.

Becton, Dickinson and Company, Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc., Beckman Coulter, Pacific Biosciences of California, Promega Corporation, are some of the prominent players operating in the NGS sample preparation market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with NGS sample preparation products.

Insights Presented in the Report

"Amongst Product, reagents & consumables segment holds the major share"

Based on product, the NGS sample preparation market is segmented into workstations and reagents & consumables. In 2020, the reagents & consumables segment accounted for a significant market share, and it is projected that it will exhibit considerable growth during the forecast period owing to the rising number of sequencing procedures and the launch of new and advanced consumables. In addition, the growing adoption of next-generation sequencing because of the availability of research grants, decreasing cost of sequencing, and increasing application of NGS in various fields are also contributing to the growth of this segment.

"Amongst Library Preparation, DNA segment holds the major share"

Based on library preparation, the NGS sample preparation market is divided into DNA, RNA, target enrichment, and quality control. The DNA segment accounted for a significant market share in 2020 and it is estimated that it will exhibit considerable growth during the forecast period as DNA is most commonly used for sequence profiling in the next-generation sequencing procedures. Library preparation allows DNA to adhere to the sequencing flowcell and allows the sample to be identified.

"Amongst Technology, sequencing by synthesis segment holds the major share"

Based on technology, the market is fragmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, and other technologies. In 2020, the sequencing by synthesis (SBS) technology segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast. This segment is expected to grow as Illumina sequencing technology, sequencing by synthesis (SBS) is widely adopted NGS technology across the world and responsible for generating more than 90% of the world's sequencing data. Further, the increase in the availability of NGS platforms based on SBS is driving the growth of the segment.

"Amongst Application, disease diagnostics segment holds the major share"

Based on application, the NGS sample preparation market is divided into disease diagnostics, drug discovery, and agriculture and animal research. The disease diagnostics segment occupied the major share of the NGS sample preparation market in 2020 and it is expected to grow with substantial CAGR in the upcoming years. The growth of this segment is attributed to the growing prevalence of various diseases such as cancer, infectious, and other rare diseases. For instance, according to the World Health Organization, more than 13 million people die from infectious diseases each year. Further, in some developing countries, it leads to 1 in 2 deaths annually.

"Amongst End-Users, academic institutes and research centers segment holds the major share"

Based on end-users, the market is fragmented into academic institutes and research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end-users. In 2020, the academic institutes & research centers segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast. This is because of the increasing adoption of NGS in cancer research for identifying new cancer-related genes and to study modifications that may contribute to tumorigenesis. In addition, Promulgating strategic alliances between NGS market players and academic & research centers and the availability of funds for genomics R&D across the globe are also some of the major factors contributing to the growth of this segment.

"North America represents one of the largest markets of NGS sample preparation market"

For a better understanding of the market dynamics of the NGS sample preparation market, a detailed analysis was conducted for different regions across the globe including North America (U.S, Canada, and Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the NGS sample preparation market industry and generated revenue of USD XX Million in 2020 owing to strong healthcare infrastructure and growing adoption of advanced technological solutions in the healthcare industry in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The global NGS sample preparation market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stake Holders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the NGS Sample Preparation Market
• 2.2. Research Methodology of the NGS Sample Preparation Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the NGS Sample Preparation Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL NGS SAMPLE PREPARATION MARKET COVID-19 IMPACT

6 GLOBAL NGS SAMPLE PREPARATION MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

• 7.1. Workstations
• 7.2. Reagents & Consumables

8 MARKET INSIGHTS BY LIBRARY PREPARATION

• 8.1. DNA
• 8.2. RNA
• 8.3. Target Enrichment
• 8.4. Quality Control

9 MARKET INSIGHTS BY TECHNOLOGY

• 9.1. Sequencing by Synthesis (SBS)
• 9.2. Ion Semiconductor Sequencing
• 9.3. Nanopore Sequencing
• 9.4. Others

10 MARKET INSIGHTS BY APPLICATION

• 10.1. Disease Diagnostics
• 10.2. Drug Discovery
• 10.3. Agricultural and Animal Research

11 MARKET INSIGHTS BY END-USERS

• 11.1. Academic Institutes and Research Centers
• 11.2. Hospitals & Clinics
• 11.3. Pharmaceutical & Biotechnology Companies
• 11.4. Others

12 MARKET INSIGHTS BY REGION

• 12.1. North America NGS Sample Preparation Market
  • 12.1.1. United States
  • 12.1.2. Canada
  • 12.1.3. Rest of North America
• 12.2. Europe NGS Sample Preparation Market
  • 12.2.1. Germany
  • 12.2.2. France
  • 12.2.3. United Kingdom
  • 12.2.4. Italy
  • 12.2.5. Spain
  • 12.2.6. Rest of Europe
• 12.3. Asia Pacific NGS Sample Preparation Market
  • 12.3.1. China
  • 12.3.2. Japan
  • 12.3.3. India
  • 12.3.4. Australia
  • 12.3.5. Rest of Asia Pacific
• 12.4. Rest of World NGS Sample Preparation Market

13 NGS SAMPLE PREPARATION MARKET DYNAMICS

• 13.1. Market Drivers
• 13.2. Market Challenges
• 13.3. Impact Analysis

14 NGS SAMPLE PREPARATION MARKET OPPORTUNITIES

15 NGS SAMPLE PREPARATION MARKET TRENDS

16 LEGAL & REGULATORY FRAMEWORK

17 DEMAND AND SUPPLY SIDE ANALYSIS

• 17.1. Demand Side Analysis
• 17.2. Supply Side Analysis
  • 17.2.1. Top Product Launches
  • 17.2.2. Top Merger and Acquisitions
  • 17.2.3. Top Business Partnerships
  • 17.2.4. Top Business Expansions, Investments and Divestitures

18 VALUE CHAIN ANALYSIS

19 COMPETITIVE SCENARIO

• 19.1. Porter's Five Forces Analysis
  • 19.1.1. Bargaining power of Supplier
  • 19.1.2. Bargaining power of Buyer
  • 19.1.3. Industry Rivalry
  • 19.1.4. Availability of Substitute
  • 19.1.5. Threat of new Entrants
• 19.2. Competitive Landscape
  • 19.2.1. Company Shares, By Revenue

20 COMPANY PROFILED

• 20.1. Thermo Fisher Scientific
• 20.2. Illumina Inc.
• 20.3. QIAGEN N.V.
• 20.4. Agilent Technologies, Inc.
• 20.5. F. Hoffmann-La Roche Ltd.
• 20.6. Integrated DNA Technologies, Inc.
• 20.7. Beckman Coulter
• 20.8. Pacific Biosciences of California
• 20.9. Becton, Dickinson and Company
• 20.10. Promega Corporation

21 DISCLAIMER